SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03050554 · TERMINATED
Trial details
- NCT number
- NCT03050554
- Sponsor
- Andrew Sharabi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-26
- Primary completion
- 2019-10-07
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.